PVI
FTH

Pura Vida Investments’s Faeth Therapeutics FTH Stock Holding History

Pura Vida Investments’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,130
Closed -$238K – 303
2021
Q3 		$238K Hold
1,130
– – 0.01% 267
2021
Q2 		$208K Sell
1,130
-2,238
-66% -$553K 0.01% 210
2021
Q1 		$941K Buy
+3,368
New +$1.13M 0.03% 194

Other funds holding FTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Pura Vida Investments's FTH Position: Q4 2021 in Review

Pura Vida Investments sold out of Faeth Therapeutics (FTH) in Q4 2021, closing a stake of 1,130 shares — an estimated $238K sold.

Pura Vida Investments first reported a position in FTH in Q1 2021 and held it in 3 quarters. The position peaked at $941K in Q1 2021. 37 funds tracked by Wall St. Rank hold FTH as of Q4 2021.

  • Pura Vida Investments reported no remaining Faeth Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Pura Vida Investments sold 1,130 Faeth Therapeutics shares in Q4 2021, an estimated $238K.
  • Pura Vida Investments first reported a position in Faeth Therapeutics in Q1 2021 and held it in 3 quarters.
  • Pura Vida Investments's Faeth Therapeutics position peaked at $941K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.